ClinicalTrials.govpublic full text
Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma
hepatocellular carcinoma (hcc), hcc, il-6, immunotherapy, tocilizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807035
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.